Our Research & Researchers

We have achieved a critical mass of investment here in Oxford and the opportunities for cancer research are immense. 

The Centre is committed to delivering early detection and precision medicine for cancer patients. We seek to do this through applying Oxford’s world leading scientific capabilities cancer types where we have critical mass of world leading translational know-how. To facilitate this we invest in infrastructure and resources which enable us to move research along the translational pipeline as summarised in the sections below.

About OCRC

Oxford’s Cancer Researchers

Our memberships spans all Departments across the Medical Sciences and Maths and Physical Life Sciences Divisions of the University, with 258 research groups and over 650 members in more than 22 Departments, Institutes, and Units producing over 18,000 co-authored publications in the last 7 years.

Follow the link to find out more about our members.

Research themes

Research Showcase

To support the delivery of the Centre’s vision, we have focused our activity in key themes with our investments emphasising support for translational activity.

Our research activity in various themes is showcased here.


Networks & Consortia

We provide leadership and drive to enable researchers from collaborating organisations to support improved clinical decision making.

Click ‘learn more’ to find out about some of the projects we support.


Clinical Studies

Oxford is a world leading centre for early phase clinical trials. The centre supports trials concerned with the practical application of high quality research into innovative and effective cancer therapies and prevention strategies.

Find out more about the trials we support and the translational progress being made.